New hope for rare blood cancers: international trial tests smart drug cocktails
Disease control
Recruiting now
This study tests new combinations of drugs for people with MDS/MPN, a group of rare blood cancers. The goal is to find safe and effective doses of these drug combos to better control the disease. About 94 adults will take part, receiving an oral drug called ASTX727 plus another t…
Phase: PHASE1, PHASE2 • Sponsor: Michael Savona • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC